Division of Urologic Surgery

Medicine & Life Sciences

1. Prostatic Neoplasms 100%
2. Nephrectomy 65%
3. Prostate 48%
4. Kidney 39%
5. Prostatectomy 37%
6. Prostate-Specific Antigen 36%
7. Robotics 32%
8. Dutasteride 31%
9. Urinary Bladder 27%
10. Neoplasms 27%
11. Biopsy 25%
12. Early Detection of Cancer 21%
13. Prostatic Hyperplasia 20%
14. Pelvic Pain 20%
15. Renal Cell Carcinoma 19%
16. Lower Urinary Tract Symptoms 18%
17. Urinary Bladder Neoplasms 18%
18. Chronic Pain 15%
19. Interstitial Cystitis 14%
20. Therapeutics 13%
21. Cystectomy 13%
22. Ovarian Neoplasms 12%
23. Lung Neoplasms 11%
24. Colorectal Neoplasms 10%
25. Finasteride 10%
26. Laparoscopy 10%
27. Swine 10%
28. Overactive Urinary Bladder 9%
29. Surgeons 9%
30. Urinary Incontinence 9%
31. Recurrence 9%
32. Urinary Tract 9%
33. Genome-Wide Association Study 9%
34. Ureter 8%
35. Cryosurgery 8%
36. Pain 8%
37. Operative Time 8%
38. Survival 8%
39. Percutaneous Nephrolithotomy 8%
40. Placebos 8%
41. Serum 8%
42. Mortality 7%
43. Single Nucleotide Polymorphism 7%
44. Warm Ischemia 7%
45. Watchful Waiting 7%
46. Urinary Tract Infections 7%
47. Carcinoma 6%
48. Lymph Node Excision 6%
49. Confidence Intervals 6%
50. Artificial Urinary Sphincter 6%
51. Urinary Diversion 6%
52. Urologists 6%
53. Odds Ratio 6%
54. Neoplasm Grading 6%
55. Databases 6%
56. Kidney Neoplasms 6%
57. Wounds and Injuries 6%
58. Urine 6%
59. Protein-Tyrosine Kinases 6%
60. Nephroureterectomy 6%
61. Nephrons 5%
62. Incidence 5%
63. Length of Stay 5%
64. Urology 5%
65. Radiotherapy 5%
66. Castration 5%
67. Androgens 5%
68. Stress Urinary Incontinence 5%
69. Morbidity 5%
70. Digital Rectal Examination 5%
71. Population 5%
72. Safety 5%
73. Equipment and Supplies 5%
74. Comorbidity 5%
75. Quality of Life 5%
76. Multiparametric Magnetic Resonance Imaging 5%
77. Pediatrics 5%
78. Guidelines 5%
79. Magnetic Resonance Imaging 5%